Annotated Medicine and Device Lists

Lorazepam

Parenteral formulation 2 mg/ml in 1-ml ampoule Parenteral formulation 4 mg/ml in 1-ml ampoule Tablet 1-2mg Tablet 0.5 mg Tablet 2 mg

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	05. ANTICONVULSANTS/ ANTIEPILEPTICS	Others observations: Therapeutic alternatives: diazepam (injection), midazolam (injection)
Training CSamouge 2022	5. ANTICONVULSANTS/ ANTIEPILEPTICS	Others observations: Therapeutic alternatives: diazepam (injection) and midazolam (injection)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	05. ANTICONVULSANTS/ ANTIEPILEPTICS	Others observations: Therapeutic alternatives: diazepam (injection), midazolam (injection)
Training CSamouge 2022	5. ANTICONVULSANTS/ ANTIEPILEPTICS	Others observations: Therapeutic alternatives: diazepam (injection) and midazolam (injection)

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	13.11 Sedatives: Hypnotics and Anxiolytics	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	12. Anticonvulsant and antiepileptic	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	12. Anticonvulsant and antiepileptic	No observations

Information Resources: Lorazepam

No information available